[Guidelines for the management of Crohn's disease].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Volumn 59, Issue 2, 2012, Pages 141-179

  Ye, Byong Duk ^a   Yang, Suk Kyun ^b   Shin, Sung Jae ^b   Lee, Kang Moon ^b   Jang, Byung Ik ^b   Cheon, Jae Hee ^b   Choi, Chang Hwan ^b   Kim, Young Ho ^b   Lee, Heeyoung ^b   IBD Study Group of the Korean Association for the Study, ^b   of the Intestinal Diseases, ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC ANTIMETABOLITE; AZATHIOPRINE; BUDESONIDE; DRUG DERIVATIVE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MONOCLONAL ANTIBODY; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ARTICLE; CROHN DISEASE; FACTUAL DATABASE; FEMALE; FISTULA; HOSPITALIZATION; HUMAN; INTESTINE PERFORATION; MALE; PATHOLOGY; PRACTICE GUIDELINE; PREGNANCY; RECURRENT DISEASE; RISK FACTOR;

6-MERCAPTOPURINE; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIMETABOLITES, ANTINEOPLASTIC; BUDESONIDE; CROHN DISEASE; DATABASES, FACTUAL; FEMALE; FISTULA; HUMANS; INTESTINAL PERFORATION; MALE; MESALAMINE; METHOTREXATE; PREDNISOLONE; PREGNANCY; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SULFASALAZINE;

EID: 84865304258     PISSN: 15989992     EISSN: None     Source Type: Journal    
DOI: 10.4166/kjg.2012.59.2.141     Document Type: Article

References (0)